National and Kapodistrian University of Athens
Μεταβολές της ενδοθηλιακής συνθετάσης του μονοξειδίου του αζώτου (e-NOS) στον προστάτη αδένα των επιμύων μετά από αδρενεργικό αποκλεισμό
Abstract
dc:descriptionINTRODUCTION – OBJECTIVES:Autonomic sympathetic innervation of the smooth muscle of prostate tissue is achieved mainly by short adrenergic nerves, noradrenaline release and engagement of alpha-adrenergic receptors. Terazosin is a specific alpha1-adrenergic blocker that exerts its action at the prostate gland and bladder neck. The main mechanism is the relaxation of smooth muscle of the prostate gland, although during the last decade induction of apoptosis in prostate cell, without affecting the cellular proliferation, has also been extensively referred.NO has also been recognized as an important non-adrenergic, non-cholinergic neurotransmitter of lower urinary tract. Its action includes the relaxation of penile erection, inhibition of urethra’s neurotransmitters, regulation of afferent nerves in the bladder, and regulation of smooth muscle tone in prostate. NO is synthesized by NOS, whereas eNOS subtype is detected in the capillary cells of small vessels, which supply the prostate gland. The levels of expression and activity of the enzyme are reduced with aging, diabetes mellitus, metabolic syndrome and hypertension. Administration of kinazoline antagonists, such as terazosin, has been shown to increase eNOS expression.MATERIALS – METHODS:22 male Wistar rats aged 120 +/- 5 days were randomized into two groups. Group A (12 rats) was treated with terazosin hydrochloride (Hytrin ®, Abbott) at a dosage of 1,2 mg/kg per os every other day. The control Group B (10 rats) received the same amount of normal saline per os. 120 days later, the treatment was discontinued and within 24 hours, we proceeded to sacrifice the rats. The ventral prostate gland was dissected and weighed, fixed in 10% formalin solution and embedded in paraffin. The biopsies were histologically assessed and stained with eNOS using a polyclonal antibody and a standard Dako EnVisionTM + System, HRP (horseradish peroxidase) method. RESULTS:All rats survived the experimental procedure, and no terazosin related adverse events were monitored. All animals in both groups showed the expected increase in their body weights (P> 0,001). No statistically important difference was observed between Groups A and B related to body weights at the beginning and end of the experiment, alongside with the absolute and relative weight of ventral prostate gland. Terazosin did not evoke any difference in the macroscopic and microscopic appearance of prostate. Immunohistochemical staining of eNOS in endothelial small vessels cells at ventral prostate gland, showed no statistically significant difference in expression, intensity and histoscore between the two groups.CONCLUSIONS:Our study confirmed previous researchers’ data about the presence of eNOS in endothelial cells in the ventral prostate gland suggesting that eNOS distribution and the synthesis of NO possible regulates the local vasculature in the prostate gland. Terazosin treatment though, did not alter the expression of eNOS in the biopsies of the ventral prostate gland between terazosin treated and and non-treated rats suggesting that eNOS regulation in prostate gland either is not regulated by adrenergic blockade or it is regulated in a dose-dependent manner.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tzirakis, Michael
- Τζιράκης, Μιχαήλ
Subjects
dc:subject × 21- Ενδοθηλιακή συνθετάση του μονοξειδίου του αζώτου
- Μονοξείδιο αζώτου (NO)
- Προστάτης αδένας επιμύων
- Αδρενεργικός αποκλεισμός
- Τεραζοσίνη
- Βιοψίες προστάτη αδένα
- Κιναζολινικοί ανταγωνιστές
- Ανοσοϊστοχημεία
- Endothelial nitric oxide synthase
- e-NOS
- Nitric oxide (NO)
- Prostate gland of rats
- Adrenergic blockage
- Terazosin
- Prostate gland biopsies
- Kinazoline antagonists
- Immunohistochemistry
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29758